Advanced search
Start date
Betweenand

The role of gene Dapper1 a Wnt pathway inhibitor, in apoptosis triggered by TGF-beta in mesangial cells

Grant number: 12/08133-7
Support type:Scholarships in Brazil - Doctorate (Direct)
Effective date (Start): September 01, 2012
Effective date (End): December 31, 2014
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal researcher:Alexandre Holthausen Campos
Grantee:Daniele Pereira Jardim
Home Institution: Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE). Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE). São Paulo , SP, Brazil

Abstract

Diabetic nephropathy is a leading cause of end-stage renal disease, which is associated with high morbidity and mortality rates. Factors and mechanisms involved in renal injury due to diabetes are complex and poorly understood. TGF-b1, a cytokine which regulates the expression of different classes of genes, induces phenotypic modifications in glomerular cells. Recent data from our laboratory confirm that TGF-b1 mediates apoptosis in mesangial cells. Molecular mechanisms associated to this phenomenon are yet to be defined. Previous data from our group identified Dapper1 gene upregulation in response to TGF-b1 in cultured human mesangial cells. It is known that Dapper1 negatively regulates the WNT pathway, positively associated with cell survival; in addition, recent work demonstrated that Wnt is able to block apoptosis in mesangial cells exposed to high ambient glucose. We hypothesized that Dapper1 is a direct mediator TGF-b1-induced mesangial cell death. Our preliminary results demonstrate that Dapper1 overexpression increases apoptosis in mesangial cells, suggesting that this gene may be an important player in the pathophysiology of diabetic nephropathy. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.